DiaMedica Therapeutics Inc.
DMAC$445M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaMINNEAPOLIS27 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Dec 15, 2026
39wMarket Overview
Stock performance and key metrics
DMAC News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Recombinant human tissue kallikrein | Phase 3 | Acute Stroke | - | - |
DM199 | Phase 2 | Kidney Diseases | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply